Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC

Clinical trial NCT04260126 · COMPLETED

Trial details

NCT number: NCT04260126
Sponsor: PDS Biotechnology Corp.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Head and Neck Cancer Recurrent Head and Neck Cancer HPV Positive Oropharyngeal Squamous Cell Carcinoma Neoplasms, Head and Neck

Start date: 2021-03-29
Primary completion: 2025-05-14
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.